IRE1α的体性突变通过差异激活Rho GTPases来调节状细胞迁移和生存
Saie Mogre1, Lily Robinson1, Komal Sethia1
1Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Journal of cell science
|July 14, 2025
概括
细胞迁移和DNA修复的增强,促进皮肤癌 IRE1α 的突变,一个内细胞网膜蛋白质,促进皮肤癌. 这些IRE1α (需要氨基酸酶1α) 突变在瘤发育中起着不同的作用.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- IRE1α (因诺醇需要酶1α) 是一个具有酶和内核酶 (RNase) 域的内细胞网膜蛋白.
- IRE1α调节细胞对压力的反应,包括Xbp1mRNA剪接和调节其他mRNA的IRE1α依赖衰变 (RIDD).
- 在人类的各种癌症中发现IRE1α的体质突变,包括非黑色素瘤皮肤癌 (NMSC).
研究的目的:
- 调查 IRE1α 突变,特别是 NMSC 中发现的突变在皮肤癌发病过程中的作用.
- 了解这些突变对移动,DNA修复和应激反应等细胞过程的功能后果.
主要方法:
- 生成不朽的小鼠角质细胞,具有可诱导的工程和癌症相关的IRE1α突变的表达.
- 使用RNA测序 (RNA-Seq) 进行途径分析.
- 进行了体外研究,以评估细胞迁移,RhoA和Rac1激活以及对UVB辐射的反应.
主要成果:
- 与NMSC相关的IRE1α突变正在激活,与Xbp1拼接相比,显示自酸化增加和RIDD活性增强.
- RNase受损突变通过高RhoA和Angptl4.4增加了细胞迁移.
- 激活突变导致了Rac1激活的增加,DNA修复基因的丰富,光ATR的升高和UVB抗性的改善.
结论:
- 角质细胞中的IRE1α突变表现出不同的功能,有助于瘤的推广.
- 特定的IRE1α突变增强了细胞迁移和生存,这是皮肤癌发展的关键事件.
- 这些发现凸显了IRE1α失调在NMSC病变发生中的多方面的作用.
相关概念视频
01:24Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
02:38The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
01:07MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
01:31Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K